• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [21721 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2012     HAYES, Inc. Screening, brief intervention, and referral to treatment (SBIRT) for substance use among pregnant women
2012     HAYES, Inc. Screening, Brief Intervention, and Referral to Treatment (SBIRT) using remote interventions for alcohol misuse
2017     NIHR Health Technology Assessment programme Seal or Varnish? A randomised controlled trial to determine the relative cost and effectiveness of pit and fissure sealant and fluoride varnish in preventing dental decay
1994     U. S. Congress. Office of Technology Assessment (OTA) Searching for evidence: identifying health technologies that work
2008     Health Council of the Netherlands Gezondheidsraad (GR) Searchlight on radiotherapy. A vision for 2015
2020     NIHR Health Technology Assessment programme Seasonal Influenza Vaccination Effectiveness II (SIVE II): use of a large national primary care and laboratory-linked dataset to evaluate live attenuated and trivalent inactivated influenza vaccination effectiveness
2013     Belgian Health Care Knowledge Centre (KCE) Seasonal influenza vaccination: prioritizing children or other target groups? Part II: cost-effectiveness analysis
2013     NIHR Health Services and Delivery Research programme Seasonal Influenza Vaccine Effectiveness (SIVE): an observational retrospective cohort study - exploitation of a unique community-based national-linked database to determine the effectiveness of the seasonal trivalent influenza vaccine
2011     Penn Medicine Center for Evidence-based Practice (CEP) Seasonal variation in readmission rates
2016     HAYES, Inc. Sebelipase Alfa (Kanuma) for treatment of lysosomal acid lipase deficiency
2012     NIHR Horizon Scanning Centre (NIHR HSC) Sebelipase alfa for lysosomal acid lipase deficiency
2010     HAYES, Inc. Secca (Mederi Therapeutics Inc.) procedure for fecal incontinence
2017     NIHR Health Services and Delivery Research programme Seclusion and Psychiatric Intensive Care Evaluation Study (SPICES): combined qualitative and quantitative approaches to the uses and outcomes of coercive practices in mental health services
2004     Malaysian Health Technology Assessment Unit (MHTAU) Second generation endometrial ablation
2004     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Second generation endometrial ablation techniques
2015     Andalusian Health Technology Assessment Area (AETSA) Second generation prognostic genomic tests in early breast cancer: EndoPredict® y Prosigna™.
2014     Medical Services Advisory Committee (MSAC) Second Opinion for Morphological/Interpretive Pathology
2011     Agency for Healthcare Research and Quality (AHRQ) Second-generation antidepressants in the pharmacologic treatment of adult depression: an update of the 2007 comparative effectiveness review
2018     Agency for Care Effectiveness (ACE) Second-generation antipsychotic injections for treating schizophrenia
2020     Scottish Health Technologies Group (SHTG) Second-generation colon capsule endoscopy (CCE-2) for the detection of colorectal polyps – SHTG Recommendation
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Second-line therapy for patients with diabetes inadequately controlled on metformin: a systematic review and cost-effectiveness analysis
2015     HAYES, Inc. Second-wave direct-acting antivirals for hepatitis C: ledipasvir-sofosbuvir
2014     HAYES, Inc. Second-wave direct-acting antivirals for hepatitis C: Simeprevir
2015     HAYES, Inc. Second-wave direct-acting antivirals for hepatitis C: Simeprevir
2015     HAYES, Inc. Second-wave direct-acting antivirals for hepatitis C: sofosbuvir
2014     HAYES, Inc. Second-wave direct-acting antivirals for hepatitis C: Sofosbuvir and Ledipasvir
2015     NIHR Health Services and Delivery Research programme Secondary analysis and literature review of community rehabilitation and intermediate care: an information resource
2007     National Institute for Health and Care Excellence (NICE) Secondary prevention in primary and secondary care for patients following a myocardial infarction
2002     NIHR Horizon Scanning Centre (NIHR HSC) Secretin for autism spectrum disorders - horizon scanning review
2012     NIHR Horizon Scanning Centre (NIHR HSC) Secukinumab for active and progressive psoriatic arthritis
2012     NIHR Horizon Scanning Centre (NIHR HSC) Secukinumab for ankylosing spondylitis – second line
2012     NIHR Horizon Scanning Centre (NIHR HSC) Secukinumab for moderate to severe, active rheumatoid arthritis
2012     NIHR Horizon Scanning Centre (NIHR HSC) Secukinumab for plaque psoriasis
2021     Scottish Medicines Consortium (SMC) Secukinumab for the treatment of active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI) evidence in adults who have responded inadequately to nonsteroidal anti-inflammatory drugs (NSAIDs)
2015     NIHR Health Technology Assessment programme Secukinumab for treating moderate to severe plaque psoriasis
2013     Penn Medicine Center for Evidence-based Practice (CEP) Securement devices for peripherally inserted central venous catheters (PICCs) and Midline catheters
2018     Penn Medicine Center for Evidence-based Practice (CEP) Securement of Arterial Catheters
2022     Swiss Federal Office of Public Health (FOPH) Sedative-hypnotic drugs for the treatment of primary chronic insomnia disorder
2002     University HealthSystem Consortium (UHC) Sedative/hypnotics
2020     Canary Health Service Seguridad, efectividad clínica y coste-efectividad de intervenciones para la prevención del delirium en el ingreso hospitalario
2020     Canary Health Service Seguridad, efectividad y coste-efectividad de los sistemas integrados de infusión subcutánea continua de insulina más sensor de monitorización continua de glucosa
2018     Canary Health Service Seguridad, efectividad y coste-efectividad del desfibrilador automático implantable subcutáneo en prevención primaria y secundaria de muerte súbita
2013     NIHR Health Technology Assessment programme SeHCAT (Tauroselcholic [75 selenium] acid) for the investigation of bile acid malabsorption (BAM) and measurement of bile acid pool loss
2022     NIHR Health Technology Assessment programme SeHCAT (tauroselcholic [75selenium] acid) for the investigation of bile acid diarrhoea in adults: a systematic review and cost-effectiveness analysis
2020     NIHR Health Technology Assessment programme Seizure first aid training for people with epilepsy attending emergency departments and their significant others: the SAFE intervention and feasibility RCT
2006     HAYES, Inc. Selected dorsal rhizotomy for cerebral palsy
2000     HAYES, Inc. Selected dorsal rhizotomy for cerebral palsy
2018     NIHR Health Technology Assessment programme Selecting pregnant or postpartum women with suspected pulmonary embolism for diagnostic imaging: the DiPEP diagnostic study with decision-analysis modelling
2006     Andalusian Health Technology Assessment Area (AETSA) Selection and evaluation of patient-targeted Websites in the field of healthcare
1999     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Selective bowel decontamination before orthotopic liver transplantation - primary research
2008     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Selective cell apheresis in inflammatory bowel disease
2014     NIHR Health Technology Assessment programme Selective decontamination of the digestive tract in critically ill patients treated in intensive care units: a mixed-methods feasibility study (the SuDDICU study)
2002     Wessex Institute for Health Research and Development (WIHRD) Selective denervation for spasmodic torticollis
2006     Medical Services Advisory Committee (MSAC) Selective dorsal rhizotomy (nationally funded centres)
2006     National Institute for Health and Care Excellence (NICE) Selective dorsal rhizotomy for spasticity in cerebral palsy
2010     National Institute for Health and Care Excellence (NICE) Selective dorsal rhizotomy for spasticity in cerebral palsy
2011     HAYES, Inc. Selective Estrogen Receptor Modulators (SERMs) for chemoprevention of breast cancer
1999     NIHR Health Technology Assessment programme Selective estrogen receptor modulators for osteoporosis
2004     HAYES, Inc. Selective estrogen receptor modulators for primary breast cancer prevention
2009     HAYES, Inc. Selective head cooling (Olympic Cool-Cap (Natus Medical Inc.) for treatment of perinatal hypoxic-ischemic encephalopathy (HIE)
2009     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Selective IgG Apheresis for ABO-incompatible kidney transplantation. Systematic Review
2020     NIHR Health Technology Assessment programme Selective internal radiation therapies for unresectable early-, intermediate- or advanced-stage hepatocellular carcinoma: systematic review, network meta-analysis and economic evaluation
2013     Agenzia nazionale per i servizi sanitari regionali (Agenas) Selective Internal Radiation Therapy (SIRT) in colorectal liver metastases
2004     National Institute for Clinical Excellence (NICE) Selective internal radiation therapy for colorectal metastases in the liver
2002     Medical Services Advisory Committee (MSAC) Selective internal radiation therapy for hepatic metastases using SIR-Spheres(R)
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Selective internal radiation therapy using yttrium-90 microspheres for the treatment of primary or metastatic liver malignancies
2007     HAYES, Inc. Selective laser trabeculoplasty (SLT) using the Selecta 7000 (Lumenis Inc.) for treatment of primary open-angle glaucoma and ocular hypertension
2008     HAYES, Inc. Selective pancreatectomy for focal congenital hyperinsulinism (CHI)
2004     National Institute for Clinical Excellence (NICE) Selective peripheral denervation for cervical dystonia
1997     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Selective serotonin reuptake inhibitors (SSRIs) for major depression. Part 2. The cost-effectiveness of SSRIs in treatment of depression
1997     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Selective serotonin reuptake inhibitors (SSRIs) for major depression. Part I. Evaluation of the clinical literature
2009     HAYES, Inc. Selective serotonin reuptake inhibitors for the treatment of autism
2010     HAYES, Inc. Selective serotonin reuptake inhibitors in the treatment of post traumatic stress disorder
1999     Alberta Heritage Foundation for Medical Research (AHFMR) Selective testing with bone density measurement
2002     NIHR Horizon Scanning Centre (NIHR HSC) Selective tubal occlusion (Essure) for female sterilisation - horizon scanning review
2001     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Selective tubal occlusion procedure
2006     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Selegiline transdermal patch
2012     HAYES, Inc. Selenia dimensions digital tomosynthesis system (Hologic Inc.) for diagnostic mammography
1999     Health Council of the Netherlands Gezondheidsraad (GR) Selenium and its compounds: evaluation of the effects on reproduction, recommendation for classification
2010     NIHR Health Technology Assessment programme Self monitoring of blood glucose in type 2 diabetes
1999     Agency for Healthcare Research and Quality (AHRQ) Self-administered drug treatments for acute migraine headache
2018     NIHR Health Technology Assessment programme Self-care support for children and adolescents with long-term conditions: the REfOCUS evidence synthesis
2014     University of York Self-care support for people with COPD
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Self-directed cognitive behavioural therapy for adults with diagnosis of depression: systematic review of clinical effectiveness, cost-effectiveness, and guidelines
2006     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Self-expanding metallic stents (SEMS) for relieving malignant colorectal obstruction: a systematic review
2004     National Institute for Clinical Excellence (NICE) Self-harm: the short-term physical and psychological management and secondary prevention of self-harm in primary and secondary care
2015     Health Quality Ontario (HQO) Self-management and educational interventions in the postacute stroke population: a rapid review
2018     NIHR Health Technology Assessment programme Self-Management education for adults with poorly controlled epILEpsy [SMILE (UK)]: a randomised controlled trial
2013     Health Quality Ontario (HQO) Self-management support interventions for persons with chronic disease: an evidence-based analysis
2017     NIHR Health Technology Assessment programme Self-management toolkit and delivery strategy for end-of-life pain: the mixed-methods feasibility study
2012     Agency for Healthcare Research and Quality (AHRQ) Self-measured blood pressure monitoring: comparative effectiveness
2019     Swiss Federal Office of Public Health (FOPH) Self-measurement of blood glucose in patients with non-insulin treated diabetes mellitus type 2
2006     HAYES, Inc. Self-monitoring and self-management of oral anticoagulant therapy
2002     HAYES, Inc. Self-monitoring of oral anticoagulant therapy
2007     The Swedish Council on Health Technology Assessment (SBU) Self-testing and self-management of oral anticoagulation - early assessment briefs (Alert)
2015     NIHR Horizon Scanning Centre (NIHR HSC) Selumetinib for KRAS mutation-positive advanced non-small cell lung cancer – second line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Selumetinib for metastatic uveal melanoma – first line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Selumetinib with radioactive iodine therapy for differentiated thyroid cancer – first line
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Semaglutide 2 mg for type 2 diabetes
2005     HAYES, Inc. Semi-implantable electromagnetic hearing aids